These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 28425073

  • 1. Molecular therapy of primary hyperoxaluria.
    Martin-Higueras C, Torres A, Salido E.
    J Inherit Metab Dis; 2017 Jul; 40(4):481-489. PubMed ID: 28425073
    [Abstract] [Full Text] [Related]

  • 2. Molecular basis of primary hyperoxaluria: clues to innovative treatments.
    Dindo M, Conter C, Oppici E, Ceccarelli V, Marinucci L, Cellini B.
    Urolithiasis; 2019 Feb; 47(1):67-78. PubMed ID: 30430197
    [Abstract] [Full Text] [Related]

  • 3. The primary hyperoxalurias.
    Bobrowski AE, Langman CB.
    Semin Nephrol; 2008 Mar; 28(2):152-62. PubMed ID: 18359396
    [Abstract] [Full Text] [Related]

  • 4. Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria.
    Lai C, Pursell N, Gierut J, Saxena U, Zhou W, Dills M, Diwanji R, Dutta C, Koser M, Nazef N, Storr R, Kim B, Martin-Higueras C, Salido E, Wang W, Abrams M, Dudek H, Brown BD.
    Mol Ther; 2018 Aug 01; 26(8):1983-1995. PubMed ID: 29914758
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of liver and kidney proteins in a mouse model for primary hyperoxaluria type I.
    Hernández-Fernaud JR, Salido E.
    FEBS J; 2010 Nov 01; 277(22):4766-74. PubMed ID: 20977670
    [Abstract] [Full Text] [Related]

  • 6. Primary hyperoxalurias: disorders of glyoxylate detoxification.
    Salido E, Pey AL, Rodriguez R, Lorenzo V.
    Biochim Biophys Acta; 2012 Sep 01; 1822(9):1453-64. PubMed ID: 22446032
    [Abstract] [Full Text] [Related]

  • 7. [Primary hyperoxaluria: A review].
    Bouzidi H, Majdoub A, Daudon M, Najjar MF.
    Nephrol Ther; 2016 Nov 01; 12(6):431-436. PubMed ID: 27372182
    [Abstract] [Full Text] [Related]

  • 8. A molecular journey on the pathogenesis of primary hyperoxaluria.
    Cellini B.
    Curr Opin Nephrol Hypertens; 2024 Jul 01; 33(4):398-404. PubMed ID: 38602143
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1.
    Dutta C, Avitahl-Curtis N, Pursell N, Larsson Cohen M, Holmes B, Diwanji R, Zhou W, Apponi L, Koser M, Ying B, Chen D, Shui X, Saxena U, Cyr WA, Shah A, Nazef N, Wang W, Abrams M, Dudek H, Salido E, Brown BD, Lai C.
    Mol Ther; 2016 Apr 01; 24(4):770-8. PubMed ID: 26758691
    [Abstract] [Full Text] [Related]

  • 10. Primary hyperoxalurias: diagnosis and treatment.
    Ben-Shalom E, Frishberg Y.
    Pediatr Nephrol; 2015 Oct 01; 30(10):1781-91. PubMed ID: 25519509
    [Abstract] [Full Text] [Related]

  • 11. [Primary hyperoxaluria].
    Cochat P, Fargue S, Bacchetta J, Bertholet-Thomas A, Sabot JF, Harambat J.
    Nephrol Ther; 2011 Jul 01; 7(4):249-59. PubMed ID: 21636340
    [Abstract] [Full Text] [Related]

  • 12. Feasibility of hepatocyte transplantation-based therapies for primary hyperoxalurias.
    Guha C, Yamanouchi K, Jiang J, Wang X, Roy Chowdhury N, Santana A, Shapiro LJ, Salido E, Roy-Chowdhury J.
    Am J Nephrol; 2005 Jul 01; 25(2):161-70. PubMed ID: 15849463
    [Abstract] [Full Text] [Related]

  • 13. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
    Chetyrkin SV, Kim D, Belmont JM, Scheinman JI, Hudson BG, Voziyan PA.
    Kidney Int; 2005 Jan 01; 67(1):53-60. PubMed ID: 15610227
    [Abstract] [Full Text] [Related]

  • 14. Molecular etiology of primary hyperoxaluria type 1: new directions for treatment.
    Danpure CJ.
    Am J Nephrol; 2005 Jan 01; 25(3):303-10. PubMed ID: 15961951
    [Abstract] [Full Text] [Related]

  • 15. [Primary hyperoxaluria].
    Toussaint C, De Pauw L.
    Nephrologie; 1995 Jan 01; 16(6):399-406. PubMed ID: 8524446
    [Abstract] [Full Text] [Related]

  • 16. Novel therapeutic approaches for the primary hyperoxalurias.
    Belostotsky R, Frishberg Y.
    Pediatr Nephrol; 2021 Sep 01; 36(9):2593-2606. PubMed ID: 33156410
    [Abstract] [Full Text] [Related]

  • 17. Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment.
    Cochat P, Hulton SA, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, Fargue S, Groothoff J, Harambat J, Hoppe B, Jamieson NV, Kemper MJ, Mandrile G, Marangella M, Picca S, Rumsby G, Salido E, Straub M, van Woerden CS, OxalEurope.
    Nephrol Dial Transplant; 2012 May 01; 27(5):1729-36. PubMed ID: 22547750
    [Abstract] [Full Text] [Related]

  • 18. Folding Defects Leading to Primary Hyperoxaluria.
    Oppici E, Dindo M, Conter C, Borri Voltattorni C, Cellini B.
    Handb Exp Pharmacol; 2018 May 01; 245():313-343. PubMed ID: 29071511
    [Abstract] [Full Text] [Related]

  • 19. Perspectives in the assessment and management of patients with primary hyperoxaluria type I.
    Morgan SH, Watts RW.
    Adv Nephrol Necker Hosp; 1989 May 01; 18():95-106. PubMed ID: 2493726
    [Abstract] [Full Text] [Related]

  • 20. Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria.
    Plumb TJ, Swee ML, Fillaus JA.
    Am J Kidney Dis; 2013 Dec 01; 62(6):1155-9. PubMed ID: 23830800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.